Qingdao Haier Biomedical Co Ltd (688139) - Total Liabilities

Latest as of June 2026: CN¥1.16 Billion CNY ≈ $169.35 Million USD

Based on the latest financial reports, Qingdao Haier Biomedical Co Ltd (688139) has total liabilities worth CN¥1.16 Billion CNY (≈ $169.35 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Qingdao Haier Biomedical Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Qingdao Haier Biomedical Co Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Qingdao Haier Biomedical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Qingdao Haier Biomedical Co Ltd total assets.

Qingdao Haier Biomedical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Qingdao Haier Biomedical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
MicroPort Scientific Corporation F:MSK	Germany	€2.20 Billion
Telecom Argentina SA ADR NYSE:TEO	USA	$10.33 Trillion
Henan Hanwei Electronics Co SHE:300007	China	CN¥1.93 Billion
Focus Technology Co Ltd SHE:002315	China	CN¥1.91 Billion
Hunan Oil Pump SHG:603319	China	CN¥1.72 Billion
TGS ASA SP.ADR/1 F:TGC0	Germany	€1.95 Billion
Pearl Abyss Corp KQ:263750	Korea	₩319.76 Billion
Triangle Tyre Co Ltd SHG:601163	China	CN¥5.88 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Qingdao Haier Biomedical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 688139 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.66	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Qingdao Haier Biomedical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Qingdao Haier Biomedical Co Ltd (2016–2025)

The table below shows the annual total liabilities of Qingdao Haier Biomedical Co Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.17 Billion ≈ $170.96 Million	-0.09%
2024-12-31	CN¥1.17 Billion ≈ $171.11 Million	+7.70%
2023-12-31	CN¥1.09 Billion ≈ $158.87 Million	-19.02%
2022-12-31	CN¥1.34 Billion ≈ $196.18 Million	+6.31%
2021-12-31	CN¥1.26 Billion ≈ $184.54 Million	+8.89%
2020-12-31	CN¥1.16 Billion ≈ $169.46 Million	+99.30%
2019-12-31	CN¥581.08 Million ≈ $85.03 Million	-47.84%
2018-12-31	CN¥1.11 Billion ≈ $163.01 Million	+93.43%
2017-12-31	CN¥575.92 Million ≈ $84.28 Million	+154.31%
2016-12-31	CN¥226.46 Million ≈ $33.14 Million	--

About Qingdao Haier Biomedical Co Ltd

SHG:688139 China Medical Devices

Market Cap

$1.45 Billion

CN¥9.93 Billion CNY

Market Cap Rank

#7395 Global

#1606 in China

Share Price

CN¥31.36

Change (1 day)

+2.35%

52-Week Range

CN¥24.70 - CN¥37.36

All Time High

CN¥147.76